NO941347L - Process for the preparation of a human monoclonal antibody - Google Patents

Process for the preparation of a human monoclonal antibody

Info

Publication number
NO941347L
NO941347L NO941347A NO941347A NO941347L NO 941347 L NO941347 L NO 941347L NO 941347 A NO941347 A NO 941347A NO 941347 A NO941347 A NO 941347A NO 941347 L NO941347 L NO 941347L
Authority
NO
Norway
Prior art keywords
crl
antibodies
human monoclonal
cell lines
preparation
Prior art date
Application number
NO941347A
Other languages
Norwegian (no)
Other versions
NO941347D0 (en
Inventor
Howard V Raff
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from NO870476A external-priority patent/NO176924C/en
Publication of NO941347L publication Critical patent/NO941347L/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Priority to NO941347A priority Critical patent/NO941347D0/en
Publication of NO941347D0 publication Critical patent/NO941347D0/en

Links

Landscapes

  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Cellelinjer er blitt fremstilt som utskiller humane, monoklonale antistoffer som er i stand til å bindes til molekyler av forskjellige bak- teriearter. Disse antistoffer er blitt funnet å være beskyttende mot letale utfordringer av forskjellige bakterieslekter. Farmasøytiske pre- parater inneholdende disse antistoffer, som kan være i kombinasjon med andre monoklonale antistoffer, blodplasma- fraksjoner og antimikrobielle midler, og den profylaktiske og terapeutiske bruk av slike preparater ved behand- ling av infeksjoner, er beskrevet. Før innlevering av foreliggende patentsøknad ble de her beskrevne, kontinuerlig transformerte, humane cellelinjer 9B10, 4F10, 4B9, 7D7 og 9C3, deponert ved American Type Culture Collection og gitt betegnelsene CRL 90O6, CRL 9007, CRL 9008, CRL 9009 og CRL 9239.Cell lines have been prepared which secrete human monoclonal antibodies capable of binding to molecules of various bacterial species. These antibodies have been found to be protective against lethal challenges of various bacterial genera. Pharmaceutical preparations containing these antibodies, which may be in combination with other monoclonal antibodies, blood plasma fractions and antimicrobial agents, and the prophylactic and therapeutic use of such preparations in the treatment of infections, are described. Prior to filing the present patent application, the continuously described human cell lines 9B10, 4F10, 4B9, 7D7 and 9C3 described herein were deposited with the American Type Culture Collection and designated CRL 90O6, CRL 9007, CRL 9008, CRL 9009 and CRL 9239.

NO941347A 1986-02-07 1994-04-14 Process for the preparation of a human monoclonal antibody NO941347D0 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO941347A NO941347D0 (en) 1986-02-07 1994-04-14 Process for the preparation of a human monoclonal antibody

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82800586A 1986-02-07 1986-02-07
US94449586A 1986-12-19 1986-12-19
NO870476A NO176924C (en) 1986-02-07 1987-02-06 Antibody preparation for non-therapeutic use
NO941347A NO941347D0 (en) 1986-02-07 1994-04-14 Process for the preparation of a human monoclonal antibody

Publications (2)

Publication Number Publication Date
NO941347L true NO941347L (en) 1987-08-10
NO941347D0 NO941347D0 (en) 1994-04-14

Family

ID=27484149

Family Applications (1)

Application Number Title Priority Date Filing Date
NO941347A NO941347D0 (en) 1986-02-07 1994-04-14 Process for the preparation of a human monoclonal antibody

Country Status (1)

Country Link
NO (1) NO941347D0 (en)

Also Published As

Publication number Publication date
NO941347D0 (en) 1994-04-14

Similar Documents

Publication Publication Date Title
SE8605295D0 (en) MONOCLONAL ANTIBODIES CROSS-REACTIVE AND CROSSPROTECTIVE AGAINST P. AERUGINOSA SEROTYPES
SE8700467L (en) MONOCLONAL HUMAN ANTIBODY PREPARATIONS CROSS-PROTECTIVE
UA29494C2 (en) Humanized antibodies, methods for producing thereof, a method for treatment of Crohns disease, a method for treatment OF disseminated sclerosis, pharmaceutical composition
DK0585943T3 (en) Soluble ligands for CD40
NO924088L (en) ANTIBODIES, PROCEDURES FOR THEIR PREPARATION AND APPLICATION OF THEM
RU94028282A (en) Biospecific antibody, method of its preparing, monoclonal antibodies, pharmaceutical preparation, pharmaceutical sets, method of tumor cell removal, use of biospecific antibody fragment
NO972451L (en) Heterocyclyloxy and thiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and preparations and process for use thereof
DK0751781T3 (en) Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic diseases
WO1998008542A3 (en) Compounds and methods for treatment and diagnosis of mycobacterial infections
CA2093667A1 (en) Mouse monoclonal antibodies and uses thereof
FR2707882B1 (en) New protein anti-mediator therapeutic kits, preparation process and pharmaceutical compositions containing them.
DE69727142D1 (en) USE OF A BPI PROTEIN PRODUCT AS AN ANTITHROMBOTIC AGENT
EP0313378A3 (en) Methods and compositions for transient elimination of humoral immune antibodies
AU2002223462A1 (en) Use of cd28-specific monoclonal antibodies for stimulating blood cells that lackcd28
NO973875D0 (en) Procedure for simulating an immune response
DE69426767D1 (en) Anti idiotypic antibodies to gonococci and methods and compositions using them.
GEP20002257B (en) Method for Reducing Fibrin Accumulation Speed, Prophylactics of Thrombus Complications and Treatment of Blood Vessels Diseases, Medicinal Composition and Medicinal Species
AU3437497A (en) Igg immunoglobulins and f(ab')2 fragments thereof, specific for drugs and metabolites thereof, and their use for detoxification purposes
NO941347L (en) Process for the preparation of a human monoclonal antibody
WO1996020950A3 (en) Compositions and methods for treating rheumatoid arthritis
ATE205531T1 (en) LO-CD2A ANTIBODIES AND THEIR USE FOR INHIBITION OF T-CELL ACTIVATION AND GROWTH
IE871769L (en) Fluorooxirane carboxylates
ES8707296A1 (en) PROTECTIVE HUMAN MONOCLONAL ANTIBODIES TO -i(PSEUDOMONAS AERUGINOSA) EXOTOXIN A.
Lundgren Induction and suppression of the cytotoxic activity of human lymphocytes in vitro by heterologous anti-lymphocyte serum
AU6953296A (en) Lo-cd2a antibody and uses thereof for inhibiting t cell activation and proliferation